COPE
Volume 5, Issue 1 (Feb 2017)                   Res Mol Med (RMM) 2017, 5(1): 6-16 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Karkhane M, Marzban A, Lashgarian H E, Zali M R. Genetic Variations in Host Factors and their Critical Role on HCV Medication. Res Mol Med (RMM). 2017; 5 (1) :6-16
URL: http://rmm.mazums.ac.ir/article-1-227-en.html

Abstract:   (883 Views)

Although standard treatments are nearly life-saving in hepatitis C patients, all patients equalldon’t respond to such medications. To achieve an efficient therapeutic response in all patients, medications should individually alter based on genetic factor variations. Hence, having more detailed knowledge of the affective factors on the disease promotion could help us to organize an appropriate regime to treat HCV patients. In order to review recent studies on HCV-related treatments, the data was collected from the clinical and molecular studies published during the last 15 years in electronic databases such as PubMed, Google Scholar, Medline, Scopus and Web of Sciences. Thus, this literature reviews the recent clinical studies with the genetic-based aspects, especially those factors affecting the etiopathological and histological feature of hepatitis C, diagnostic genetic and viral affecting criteria as well as some effective treatment strategies.
 

Full-Text [PDF 481 kb]   (434 Downloads)    
Type of Study: review | Subject: Medical Virology
Received: 2017/04/11 | Accepted: 2017/06/6 | Published: 2017/06/6

Add your comments about this article : Your username or Email:
Write the security code in the box

Send email to the article author


© 2015 All Rights Reserved | Research in Molecular Medicine

Designed & Developed by : Yektaweb